header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-TALEN-171120-4
TALEN Name: TALEN3-cyp19a1a
Target: cyp19a1a (1)
Source:
Target Sequence 1:
5' - AAGGAAGTCTTTGTAC - 3'
   
Select Sequence Analysis Tool

Target Sequence 2:
5' - GCAGACCCAGTTTACT - 3'
   
Select Sequence Analysis Tool

  (Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.)
TARGET LOCATION
No data available
CONSTRUCTS WITH SEQUENCES FROM TALEN3-cyp19a1a No data available
GENOMIC FEATURES CREATED WITH TALEN3-cyp19a1a
Genomic Feature Affected Genomic Regions    
zf1031 cyp19a1a    
GENE EXPRESSION
Gene expression in Wild Types + TALEN3-cyp19a1a No data available
PHENOTYPE
Phenotype resulting from TALEN3-cyp19a1a
No data available

Phenotype of all Fish created by or utilizing TALEN3-cyp19a1a
Phenotype Fish Conditions Figures
whole organism sox9a expression amount, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
whole organism ar expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 7 from Yin et al., 2017
male gonad development delayed, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 6 from Yin et al., 2017
female organism estradiol decreased amount, abnormal cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 4 from Yin et al., 2017
whole organism dmrt1 expression amount, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
whole organism foxl2a expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 7 from Yin et al., 2017
blood estradiol absent, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 2 from Yin et al., 2017
whole organism amh expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 7 from Yin et al., 2017
whole organism sox9a expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 7 from Yin et al., 2017
immature gonad absent, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 6 from Yin et al., 2017
male organism 11-oxotestosterone increased amount, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 3 from Yin et al., 2017
female sex determination disrupted, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 2 from Yin et al., 2017
whole organism dmrt1 expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 7 from Yin et al., 2017
female organism present, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 4 from Yin et al., 2017
male organism present, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 4 from Yin et al., 2017
whole organism sf1 expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 7 from Yin et al., 2017
whole organism amh expression amount, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
whole organism ar expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
whole organism amh expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
immature gonad present, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 6 from Yin et al., 2017
female organism absent, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 2 from Yin et al., 2017
whole organism foxl2a expression amount, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
male gonad development delayed, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 6 from Yin et al., 2017
whole organism sf1 expression decreased amount, abnormal cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
female sex determination occurrence, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 4 from Yin et al., 2017
whole organism sf1 expression amount, ameliorated cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 7 from Yin et al., 2017
male organism testosterone increased amount, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 3 from Yin et al., 2017
male organism proportionality to female organism, abnormal cyp19a1azf1031/zf1031(AB) standard conditions Fig. 2 from Yin et al., 2017
female organism absent, abnormal cyp19a1bzf1032/zf1032 ; cyp19a1azf1031/zf1031(AB) standard conditions Fig. 2 from Yin et al., 2017
blood estradiol absent, abnormal cyp19a1bzf1032/zf1032 ; cyp19a1azf1031/zf1031(AB) standard conditions Fig. 2 from Yin et al., 2017
female sex determination disrupted, abnormal cyp19a1bzf1032/zf1032 ; cyp19a1azf1031/zf1031(AB) standard conditions Fig. 2 from Yin et al., 2017
male gonad development delayed, abnormal cyp19a1bzf1032/zf1032 ; cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 6 from Yin et al., 2017
male organism proportionality to female organism, abnormal cyp19a1bzf1032/zf1032 ; cyp19a1azf1031/zf1031(AB) standard conditions Fig. 2 from Yin et al., 2017
immature gonad absent, abnormal cyp19a1bzf1032/zf1032 ; cyp19a1azf1031/zf1031(AB) chemical treatment by environment: 17beta-estradiol Fig. 6 from Yin et al., 2017
OTHER TALEN3-cyp19a1a TALEN PAGESNo links to external sites
CITATIONS (2)